The Center for Clinical Spectroscopy is comprised of a multidisciplinary team of scientists and collaborating clinicians whose goal is to translate magnetic resonance spectroscopy (MRS) into the clinic through technical development, clinical applications, and advocacy. Novel hardware and software advances in multinuclear spectroscopy and multidimensional spectral and spatial encoding enables non-invasive, objective, and quantitative ‘virtual biopsy’ measures of brain and body chemistry that provide biomarkers for early diagnosis and treatment monitoring across a broad range of diseases.

Our current studies include traumatic brain injury, neurodegenerative disorders, cancer, psychiatric disorders, metabolic and immune disorders, chronic pain, diabetes, and continued expansion to additional clinical applications through funding from the National Institutes of Health, Department of Defense, and industry. The ultimate goal of the Center is to bridge the gap between research and clinical practice for MRS through promotion of this powerful technique at the local, national, and international levels via mentorship, training, education, and advocacy.